About CIBA VISION

With a focus on innovation, quality and strong partnerships with eye care professionals, CIBA VISION is a global leader in the research, development and manufacturing of contact lenses and lens care products. CIBA VISION shares the eye care professional’s passion for healthy vision and dedication to improving the quality of patients’ lives around the world. Headquartered in Atlanta, Georgia, we provide solutions that fit the lifestyles, preferences and needs of people in more than 70 countries around the world.

CIBA VISION is committed to innovation - exploring new materials and devices that continue to yield eye care breakthroughs. Our research & development (R&D) efforts have produced lenses such as O2OPTIX™, high-oxygen, breathable lenses for healthy eyes; NIGHT & DAY®, high-oxygen extended wear lenses that can be worn for up to 30 continuous nights; and Focus® DAILIES®, daily disposable contact lenses.

Additionally, we are the leading international provider of cosmetic contact lenses to change and enhance eye color. CIBA VISION FreshLook® lenses enable you to change, enhance or illuminate your eyes. CIBA VISION offers the widest variety of colors, modalities and cosmetic contact lens styles - more than 85 combinations in all - of any contact lens manufacturer.

In lens care, CIBA VISION has pioneered many products, such as Aquify® 5 Minutes Multi-Purpose Solution and Clear Care® (also marketed as SOLO-care Aqua™ and AOSept Plus™ respectively outside the U.S.).

Parent Company

As the eye care unit of Novartis AG, CIBA VISION benefits from the strengths and resources of one of the largest healthcare companies in the world. Novartis is a world leader in healthcare, with core businesses in pharmaceuticals, consumer health, pediatrics, eye care and animal health.

Headquartered in Basel, Switzerland, Novartis companies employ approximately 80,000 people and operate in more than 140 countries around the world. In 2005, the Group's businesses achieved collective sales of approximately USD 32.2 billion and a net income of approximately USD 6.1 billion. Together, CIBA VISION and Novartis share a vision of developing new products that bring new hope and improve the lives of people around the globe.